methanandamide

1.	Christensson, Birger: 1 article (11/2006)
2.	Sander, Birgitta: 1 article (11/2006)
3.	Gustafsson, Kristin: 1 article (11/2006)
4.	Flygare, Jenny: 1 article (11/2006)
5.	Gardner, Brian: 1 article (11/2003)
6.	Sharma, Sherven: 1 article (11/2003)
7.	Tashkin, Donald P: 1 article (11/2003)
8.	Zhu, Li X: 1 article (11/2003)
9.	Dubinett, Steven M: 1 article (11/2003)
10.	Uzhachenko, R V: 1 article (05/2002)

Related Diseases

1.	Coronary Occlusion 02/01/2002 - "Stimulation of cannabinoid receptors with endogenous cannabinoid anandamide and its enzyme-resistant analogue R-(+)-methanandamide improved cardiac resistance to arrhythmias induced by coronary occlusion and reperfusion" Get all the results and reference details, order at left...
2.	Status Epilepticus (Complex Partial Status Epilepticus) 03/08/2007 - "Methanandamide and 2-AG inhibited status epilepticus in a dose-dependent manner with an EC(50) of 145+/-4.15 nM and 1.68+/-0.19 microM, respectively" 03/08/2007 - "These results provide the first evidence that the endocannabinoids, methanandamide and 2-AG, are effective inhibitors of refractory status epilepticus in the hippocampal neuronal culture model and indicate that regulating the endocannabinoid system may provide a novel therapeutic approach for treating refractory status epilepticus." 03/08/2007 - "In addition, the anti-status epilepticus effects of methanandamide and 2-AG were mediated by activation of the cannabinoid CB(1) receptor since they were blocked by the cannabinoid CB(1) receptor antagonist AM251" 03/08/2007 - "This study evaluated the effects of the major endocannabinoids methanandamide and 2-arachidonylglycerol (2-AG) on status epilepticus in the low-Mg(2+) hippocampal neuronal culture model" Get all the results and reference details, order at left...
3.	Plasma Cell Leukemia 09/01/2008 - "In functional studies using MCL, Burkitt lymphoma (BL), chronic lymphatic leukemia (CLL) and plasma cell leukemia cell lines, the stable anandamide analog R(+)-methanandamide (R(+)-MA) induced cell death only in MCL and CLL cells, which overexpressed both cannabinoid receptors, but not in BL" Get all the results and reference details, order at left...
4.	Leukemia 09/01/2008 - "In functional studies using MCL, Burkitt lymphoma (BL), chronic lymphatic leukemia (CLL) and plasma cell leukemia cell lines, the stable anandamide analog R(+)-methanandamide (R(+)-MA) induced cell death only in MCL and CLL cells, which overexpressed both cannabinoid receptors, but not in BL" Get all the results and reference details, order at left...
5.	Hyperalgesia 11/01/2008 - "In the present study, correlative behavioral and in vivo electrophysiological studies were conducted to determine if peripheral administration of the cannabinoid receptor agonists arachidonyl-2'-chloroethylamide (ACEA) or (R)-(+)-methanandamide (methAEA) could attenuate mechanical allodynia and hyperalgesia, and decrease mechanically evoked responses of Adelta nociceptors" Get all the results and reference details, order at left...
19 Diseases and 16 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Cannabinoid Receptors (Cannabinoid Receptor)
2.	anandamide (arachidonylethanolamide)
3.	Endocannabinoids (Endocannabinoid)
4.	2-arachidonylglycerol (2-arachidonoylglycerol)
5.	rimonabant
6.	Win 55212-2 (WIN 55,212)
7.	CB2 Cannabinoid Receptor
8.	CB1 Cannabinoid Receptor (CB1 Receptor)
9.	NG-Nitroarginine Methyl Ester (L-NAME)
10.	Dinoprostone (PGE2)
25 Drugs and Important Bio-Agents and 15 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>